SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17195414
Source:
http://linkedlifedata.com/resource/pubmed/id/17195414
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003241
,
umls-concept:C0003873
,
umls-concept:C0030705
,
umls-concept:C0030956
,
umls-concept:C0035448
,
umls-concept:C0087111
,
umls-concept:C0666743
pubmed:issue
11
pubmed:dateCreated
2007-1-1
pubmed:abstractText
To investigate the impact of infliximab treatment on anticyclic citrullinated peptide (anti-CCP) antibody and rheumatoid factor (RF) levels in patients with rheumatoid arthritis (RA).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0404522
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin A
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic
,
http://linkedlifedata.com/resource/pubmed/chemical/Rheumatoid Factor
,
http://linkedlifedata.com/resource/pubmed/chemical/cyclic citrullinated peptide
,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0038-4348
pubmed:author
pubmed-author:AhmedM MubashirMM
,
pubmed-author:BerneySeth MarkSM
,
pubmed-author:HallVickyV
,
pubmed-author:HayatSaminaS
,
pubmed-author:MubashirEishaE
,
pubmed-author:ShiRunhuaR
,
pubmed-author:WolfRobert ERE
pubmed:issnType
Print
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1209-15
pubmed:meshHeading
pubmed-meshheading:17195414-Adult
,
pubmed-meshheading:17195414-Aged
,
pubmed-meshheading:17195414-Antibodies, Monoclonal
,
pubmed-meshheading:17195414-Antirheumatic Agents
,
pubmed-meshheading:17195414-Arthritis, Rheumatoid
,
pubmed-meshheading:17195414-Female
,
pubmed-meshheading:17195414-Humans
,
pubmed-meshheading:17195414-Immunoglobulin A
,
pubmed-meshheading:17195414-Immunoglobulin M
,
pubmed-meshheading:17195414-Male
,
pubmed-meshheading:17195414-Middle Aged
,
pubmed-meshheading:17195414-Peptides, Cyclic
,
pubmed-meshheading:17195414-Rheumatoid Factor
pubmed:year
2006
pubmed:articleTitle
Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
pubmed:affiliation
Center of Excellence for Arthritis and Rheumatology, LSU-HSC-S, 1501 Kings Highway, Shreveport, LA 71130, USA. mahmed3@lsuhsc.edu
pubmed:publicationType
Journal Article